Fluicell
Business Services · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Flöjelbergsgatan 8c, Moelndal, Vaestra G...Phone Number
+46 762083354Website
www.fluicell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Fluicell
Fluicell is a pioneering company in high precision tissue engineering and microfluidics, focused on transforming disease treatment through its innovative Nexocyte tissue therapeutics platform. This platform, built on two decades of R&D, aims to create transplantable tissues for serious diseases such as type 1 diabetes, cardiac, pulmonary, and kidney diseases. Fluicell's products also enhance drug screening capabilities for pharmaceutical partners, enabling the development of groundbreaking medicines. The company targets innovation-driven pharmaceutical companies as its primary clients, seeking collaborations to advance regenerative medicine.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fluicell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Fluicell has new funding data
Check if Fluicell has recently received funding, and reach out quickly before it becomes old news!
Click to see if Fluicell had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Fluicell
Product Launch: Get notified when Fluicell launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Fluicell is spiking on competitors!
Earning: See what the market has to say on Fluicell recently announced quarterly report
Fluicell, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Fluicell
Find 3 more new buyers
Compare Similar Companies to Fluicell
Compare insights from companies similar to Fluicell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Fluicell
<$5M
11-50
Private
-
2012
N/A
Company Profile Activity
Activity Insights
Fluicell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fluicell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fluicell.
Fluicell Tech Stack
A closer look at the technologies used by Fluicell
Fluicell News & Media
BioStock: Fluicell launches Biozone 6
When it comes to single-cell technology for research and development, Swedish Fluicell are considered pioneers in the field, offering a wide range of products based on the properties of microfluidics, which enable manipulation of individual cells in a lab environment with high precision. This week, the company launched its latest product, Biozone 6, a new concept within the field that brings versatility to high-resolution single-cell pharmacology applications. Read the full article at biostock.sBioStock: 2020 - a year of growth and expansion for Fluicell
Fluicell began 2020 with the first sale of its then new product, Biopixlar; by the end of the year, the single cell pioneers were able to announce a fourth product based on microfluidic technology. In between, Fluicell has expanded as a company, both in terms of services and in terms of distribution partnerships, and sales of its R&D products have kept strong. BioStock spoke with CEO Victoire Viannay to get her view of the progressBioStock: Fluicell harnessing microfluidics to spearhead the Biomedical field
Despite being a small company, Fluicell has already positioned itself as a pioneer in the field of single-cell investigations by developing innovative technologies. To reach such heights, the company’s products are based on advanced microfluidic technology, allowing for the precise control of fluids within a biomedical research setting. To learn more about this technology and how Fluicell has leveraged it in its product development, BioStock reached out to the company’s co-founder and CTO GavinBioStock: Fluicell makes its mark in neuroscience field
Neurodegenerative diseases are a rapidly growing concern with an increasingly aging population. Decades of research have made it possible to generate neuronal cell cultures in a lab to study their behaviour in disease or injury models or for drug testing. However, these man-made cells lack the complexity of neural tissue to appropriately replicate natural behaviour inside the human body. Gel-free bioprinting has the capacity to address this issue, and Biopixar, Fluicell’s 3-D bioprinter, has sho
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fluicell
Sign Up For FreeTo access detailed company insights
Fluicell is a pioneering company in high precision tissue engineering and microfluidics, focused on transforming disease treatment through its innovative Nexocyte tissue therapeutics platform. This platform, built on two decades of R&D, aims to create transplantable tissues for serious diseases such as type 1 diabetes, cardiac, pulmonary, and kidne... Read More
